J. Bradley White J. Bradley White

The impact of stronger drug dosing patents on Canadian drug access

A consistent pain point and focus of reform within the system is the high cost of prescription drugs.

U.K. appellate court rules artificial neural network application is not patent-eligible subject matter

Although artificial neural networks (ANNs) have evolved to increasingly form the backbone of modern commerce, their patentability remained...

Canadian Intellectual Property Office (CIPO) increasing official fees effective January 1, 2024

CIPO is set to substantially increase official fees for patents, trademarks, industrial designs and copyrights on January 1, 2024.

Canadian Court again rejects problem-solution approach to subject-matter eligibility of computer-implemented patents

The Federal Court of Canada has once again rejected the problem-solution approach to determining eligibility for computer-implemented patent...

Act now: Request examination early to avoid excess claims fees and other restrictions under proposed new Canadian Patent Rules

The Government of Canada is proposing amendments to the Canadian Patent Rules that will introduce excess claims fees and a Request for Continued...

Time to talk about ownership of AI-generated intellectual property assets

Systems for protecting intellectual property (IP) have been in place since the Middle Ages, encouraging skilled, innovative technicians by granting...